CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net loss	$ (30,170)	$ (35,816)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	12,725	4,353
Amortization of debt issuance costs and discount on convertible debt	6,969	1,913
Stock-based compensation	2,462	0
Provision for bad debt expense	(37)	0
Impairment of property, plant and equipment, intangible assets and goodwill	5,459	0
Gain on extinguishment of debt	0	(151)
Loss from equity method investment	0	561
Gain on consolidation of equity method investment	0	(640)
Gain on fair value of warrant liabilities	(190)	(1,075)
Gain on fair value of derivative liability	(6,670)	0
Loss on disposal of property and equipment	0	78
Deferred income taxes	(4,596)	(7,262)
Other	0	(271)
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable	(6,151)	(21,000)
Inventories	(55)	(80)
Prepaid expenses and other current assets	540	5
Accounts payable and accrued expenses	7,913	15,573
Income taxes payable	264	200
Deferred revenue	3,838	5,877
Proceeds from Provider Relief Funds	0	506
Due to related parties	170	28
Other current liabilities	(312)	(27)
Net cash used in operating activities	(7,841)	(37,228)
Investing activities:
Purchases of property and equipment	(3,783)	(669)
Due to related parties	0	265
Net cash acquired in acquisition of businesses	0	4,263
Net cash (used in) provided by investing activities	(3,783)	3,859
Financing activities:
Proceeds from merger and recapitalization transaction	0	83,435
Proceeds from convertible debt	0	164,500
Repayments of debt	(3,234)	(17,333)
Payments of debt issuance costs	0	(8,100)
Repayment of forward share purchase	(18,521)	0
Repayments of seller notes	0	(88,056)
Payments of capital lease obligations	(1,619)	(275)
Payments for taxes related to net settlement of equity awards	(67)	0
Distribution to noncontrolling interest	(139)	(100)
Payments of amount due to member	0	(4,270)
Net cash (used in) provided by financing activities	(23,580)	129,801
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(460)	(99)
Net (decrease) increase in cash, cash equivalents, and restricted cash	(35,664)	96,333
Cash, cash equivalents, and restricted cash, beginning of period	76,801	2,369
Cash, cash equivalents, and restricted cash, end of period	41,137	98,702
Supplemental cash flow information:
Cash paid for interest	5,269	233
Cash paid for income taxes	521	0
Property, plant and equipment reclassed from other assets	3,751	0
Property and equipment acquired through capital lease and vendor financing arrangements	1,628	0
FIN 48 liability reclassed from deferred tax liabilities	1,750	0
Unremitted taxes related to net settlement of equity awards	1,158
Issuance of common stock for debt conversion	0	1,879
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	40,629	98,116
Restricted cash	508	586
Total cash, cash equivalents, and restricted cash	41,137	98,702
TTC
Issuance of common stock and promissory note to consummate business combination	0	43,306
Glocal
Issuance of common stock and promissory note to consummate business combination	0	110,421
Innovations Group
Issuance of common stock and promissory note to consummate business combination	0	160,378
Cloudbreak
Issuance of common stock and promissory note to consummate business combination	$ 0	$ 106,284